Teva Pharmaceutical Industries Ltd
TASE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd Logo
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Watchlist
Price: 6 340 ILS 0.32% Market Closed
Market Cap: 71.4B ILS
Have any thoughts about
Teva Pharmaceutical Industries Ltd?
Write Note

Relative Value

The Relative Value of one TEVA stock under the Base Case scenario is 10 812.16 ILS. Compared to the current market price of 6 340 ILS, Teva Pharmaceutical Industries Ltd is Undervalued by 41%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TEVA Relative Value
Base Case
10 812.16 ILS
Undervaluation 41%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
6
vs Industry
66
Median 3Y
0.7
Median 5Y
0.7
Industry
2.5
Forward
1.2
vs History
vs Industry
Median 3Y
-7.6
Median 5Y
-5
Industry
21.9
Forward
689.5
vs History
20
vs Industry
29
Median 3Y
9.5
Median 5Y
10.3
Industry
16.5
vs History
vs Industry
17
Median 3Y
-9.4
Median 5Y
-7.5
Industry
23.6
vs History
6
vs Industry
30
Median 3Y
1.3
Median 5Y
1.1
Industry
2.1
vs History
17
vs Industry
50
Median 3Y
1.8
Median 5Y
1.9
Industry
2.6
Forward
2
vs History
39
vs Industry
48
Median 3Y
3.7
Median 5Y
3.8
Industry
5.2
vs History
33
vs Industry
41
Median 3Y
6.2
Median 5Y
6.5
Industry
13.3
Forward
6.9
vs History
47
vs Industry
38
Median 3Y
8.6
Median 5Y
9
Industry
16.6
Forward
8.1
vs History
39
vs Industry
19
Median 3Y
24.4
Median 5Y
26.1
Industry
15.6
vs History
39
vs Industry
12
Median 3Y
48.4
Median 5Y
45.7
Industry
19.1
vs History
6
vs Industry
62
Median 3Y
0.7
Median 5Y
0.7
Industry
1.9

Multiples Across Competitors

TEVA Competitors Multiples
Teva Pharmaceutical Industries Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Teva Pharmaceutical Industries Ltd
TASE:TEVA
71.4B ILS 1.2 -40.5 7 9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IL
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Average P/E: 32.4
Negative Multiple: -40.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top